Peak Clarity: Banish Brain Fog

"Brain fog" is not a formal diagnosis, and it has no validated, consistent QEEG signature. Some EEG studies report increased frontal or central theta, slowed alpha peak frequency, or altered connectivity in conditions involving cognitive fatigue or impairment, but these findings are not specific to brain fog. QEEG may show such patterns in some individuals, though results vary and are not diagnostically definitive. Neurofeedback uses operant conditioning to modulate targeted EEG activity, such as reducing slow-wave power, though reliable clinical benefit for cognitive complaints is not firmly established. Some studies report subjective or cognitive improvements following neurofeedback, but the evidence is mixed and limited by methodological weaknesses such as small samples and inadequate sham controls. It is one tool to consider, not a cure, and a meaningful minority of people do not respond.

QEEG measures patterns like theta/beta ratios, individual alpha peak frequency, frontal beta activity, and coherence, but these are not validated biomarkers of general cognitive inefficiency. Elevated theta/beta ratios have been associated with attentional difficulties in some ADHD research, though the findings are inconsistent and TBR is not a diagnostic marker. Lower alpha peak frequency has been correlated with slower processing speed and poorer cognitive performance, and altered frontal beta and coherence have been reported in some conditions, but none of these are established clinical markers, and no well-established research directly links them to subjective "brain fog." QEEG can show regional differences in scalp EEG activity that may inform neurofeedback protocols, but it has limited source-localization accuracy, and QEEG-guided training has not been robustly validated. It is one input among several, not a precise map of where a problem originates.

The evidence for neurofeedback in chronic fatigue syndrome and post-viral conditions is limited. Some small, preliminary studies and case reports suggest it may be associated with cognitive improvements, but this has not been established by controlled trials. QEEG studies in CFS have reported various and inconsistent findings, and no single characteristic pattern, such as excess theta with reduced alpha, has been reliably established. Whether QEEG patterns in CFS reliably change with targeted training also remains untested in controlled research. A few small or anecdotal reports note subjective gains in concentration and mental endurance, but these lack confirmation from rigorous trials. Any mechanism by which neurofeedback might affect CFS symptoms is speculative and not empirically established.